노인 다제약물 관리 프로그램의 현황과 과제open accessPolypharmacy Management Program: Current Status and Emerging Challenges in Older Patients
- Authors
- Shin, Woo-young; Song, Jung Soo; Kim, Jung-ha
- Issue Date
- Dec-2021
- Publisher
- 대한임상노인의학회
- Keywords
- Elderly; Management; Polypharmacy
- Citation
- 임상노인의학회지, v.22, no.2, pp 55 - 60
- Pages
- 6
- Journal Title
- 임상노인의학회지
- Volume
- 22
- Number
- 2
- Start Page
- 55
- End Page
- 60
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/54451
- DOI
- 10.15656/kjcg.2021.22.2.55
- ISSN
- 1229-6538
- Abstract
- Polypharmacy is a major public health concern globally with aging populations and the increase in the prevalence of multimorbidity.
This review provides an overview of polypharmacy and its management programs in older patients and describes the development direction and challenges of polypharmacy management strategies while considering the current situation in Korea. Although polypharmacy is often regarded as the routine use of at least five medications, the definition is more useful in terms of clinical appropriateness rather than the number of medications administered. The goal of polypharmacy management should be to ensure rational prescription based on clinical evidence and appropriate medication use in consideration of the patient’s individual factors. In order for doctors, nurses, and pharmacists to collaborate within a multidisciplinary team to ensure a comprehensive medication review, it would be effective to implement a management model in the form of a systematic program within the healthcare delivery system. Some countries are introducing sustainable polypharmacy management programs and developing standardized polypharmacy guidelines. It is required to conduct further benchmark studies of polypharmacy management programs in other countries that have proven their effectiveness while considering the Korean situation.
- Files in This Item
-
- Appears in
Collections - College of Medicine > ETC > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.